Opioids reduce injury from
myocardial ischemia-reperfusion in humans. In experimental models, this mechanism involves GSK3β inhibition. HSP90 regulates
mitochondrial protein import, with GSK3β inhibition increasing HSP90 mitochondrial content. Therefore, we determined whether
morphine-induced cardioprotection is mediated by HSP90 and if the protective effect is downstream of GSK3β inhibition. Male Sprague-Dawley rats, aged 8-10 weeks, were subjected to an in vivo
myocardial ischemia-
reperfusion injury protocol involving 30 minutes of
ischemia followed by 2 hours of reperfusion. Hemodynamics were continually monitored and
myocardial infarct size determined. Rats received
morphine (0.3 mg/kg), the GSK3β inhibitor,
SB216763 (0.6 mg/kg), or saline, 10 minutes prior to
ischemia. Some rats received selective HSP90 inhibitors,
radicicol (0.3 mg/kg), or
deoxyspergualin (DSG, 0.6 mg/kg) alone or 5 minutes prior to
morphine or
SB216763.
Morphine reduced
myocardial infarct size when compared to control (42 ± 2% versus 60 ± 1%). This protection was abolished by prior treatment of
radicicol or DSG (59 ± 1%, 56 ± 2%). GSK3β inhibition also reduced
myocardial infarct size (41 ± 2%) with HSP90 inhibition by
radicicol or DSG partially inhibiting SB216763-induced
infarct size reduction (54 ± 3%, 47 ± 1%, resp.). These data suggest that
opioid-induced cardioprotection is mediated by HSP90. Part of this protection afforded by HSP90 is downstream of GSK3β, potentially via the HSP-TOM mitochondrial import pathway.